Produkty 364622-33-3

CAS 364622-33-3 występuje w naszej ofercie pod nazwami: Lucidenic acid N, Lucidenic acid LM1, 99.90%, (4R)-4-((3S,5R,7S,10S,13R,17R)-3,7-Dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid, ≥98%. Oferty producentów: Biosynth, MedChemExpress, Chemat. Dostępne opakowania: 5mg, 10mg, 1 mg, 5 mg.

Lucidenic acid N
Biosynth
  • opakowanie: 5mg, 10mg
  • Warianty: 2
Zobacz produkt
Lucidenic acid LM1, 99.90%
MedChemExpress
  • opakowanie: 1 mg, 5 mg
  • Warianty: 2
od 695,86
Zobacz produkt
(4R)-4-((3S,5R,7S,10S,13R,17R)-3,7-Dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid, ≥98%
Chemat
  • opakowanie: 5mg
  • Warianty: 1
od 1542,80
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(4R)-4-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid (CAS 364622-33-3) to związek chemiczny o wzorze sumarycznym C27H40O6 i masie molowej 460.6 g/mol. Nazwa systematyczna IUPAC: (4R)-4-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid. InChIKey: YBGBNHHXOJXFNM-UQCMLMITSA-N.

Dane identyfikacyjne
Wzór sumarycznyC27H40O6
Masa molowa460.6 g/mol
Nazwa IUPAC(4R)-4-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
InChIKeyYBGBNHHXOJXFNM-UQCMLMITSA-N
SMILESC[C@H](CCC(=O)O)[C@H]1CC(=O)[C@@]2([C@@]1(CC(=O)C3=C2[C@H](C[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Lucidenic acid N, Lucidenic acid LM1, Lucidenic acid SP1, Lucidenic acid LM1;, Lucidenic acid SP1 (Lucidenic acid LM1), 3,7-Dihydroxy-25,26,27-trinor-11,15-dioxolanost-8-en-24-oic acid, 3,7-dihydroxy-4,4,14-trimethyl-11,15-dioxochol-8-en-24-oic acid, orb1684445, 3beta,7beta-Dihydroxy-4,4,14-trimethyl-11,15-dioxo-5alpha-chol-8-en-24-oic acid
Izomery (ten sam wzór sumaryczny)
[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] hexanoate C27H40O6
[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-acetyloxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate C27H40O6
5-methyl-5-[(3S,5R,7S,10S,13R,14R,15R,17S)-3,7,15-trihydroxy-4,4,10,13,14-pentamethyl-11-oxo-1,2,3,5,6,7,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]oxolan-2-one C27H40O6
[(1R)-2-[(1R,2S,4aS,4bS,8aS,10aS)-2-formyl-4b,8,8,10a-tetramethyl-2,3,4,4a,5,6,7,8a,9,10-decahydro-1H-phenanthren-1-yl]-1-[(2R)-2-hydroxy-5-oxo-2H-furan-3-yl]ethyl] acetate C27H40O6
(4R)-4-[(5R,10S,13R,14R,17R)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid C27H40O6
methyl 4-(3-acetyloxy-10,13-dimethyl-7,12-dioxo-2,3,4,5,6,8,9,11,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate C27H40O6